AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25038431 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine
Number of subjects: 1182
Study 22853197 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches (eight-week, step down program) dispensed at discharge
Number of subjects: 1640
Study 22853197 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone counseling provided by the state quitline after discharge
Number of subjects: 1640
Study 22853197 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (nicotine patches and telephone counseling)
Number of subjects: 1640
Study 22853197 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1640
Study 22853197 — intervention group
Group type: COMPARATOR
Intervention: All interventions (patch alone, counseling alone, and combined interventions)
Number of subjects: 1640
Study 19490744 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antidepressants
Number of subjects: 0
Study 19490744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17377748 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) 0.2 mg/ml applied to the osteotomy site for 30 min
Number of subjects: 35
Study 17377748 — intervention group
Group type: COMPARATOR
Intervention: Standard EXT-DCR procedure (Control)
Number of subjects: 35
Study 16014884 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-chamber pacing (fixed-rate or rate-adaptive)
Number of subjects: 2021
Study 16014884 — intervention group
Group type: COMPARATOR
Intervention: Dual-chamber pacing
Number of subjects: 2021
Study 16014884 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-chamber pacing
Number of subjects: 2021
Study 12077687 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/d enalapril
Number of subjects: 47
Study 12077687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 9445316 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 250,000 IU intrapleural streptokinase (IPSK)
Number of subjects: 16
Study 9445316 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial doses of 250,000 IU intrapleural streptokinase (IPSK) every 12 hours for 3 days (total dose: 1.5 million IU)
Number of subjects: 16
Study 8711268 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg per os 1 h before exercise
Number of subjects: 40
Study 2315637 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide (Buscopan) 20 mg i.v.
Number of subjects: 189
Study 2315637 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon 1 mg i.v.
Number of subjects: 189
Study 2315637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 7401741 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxovinca; administered over three consecutive courses within a two-month period.
Number of subjects: 33
Study 7401741 — intervention group
Group type: COMPARATOR
Intervention: Placebo; administered over three consecutive courses within a two-month period.
Number of subjects: 33
Study 7401741 — intervention group
Group type: COMPARATOR
Intervention: Control group; 10 normal individuals of comparable age.
Number of subjects: 33
Study 31999182 — intervention group
Group type: EXPERIMENTAL
Intervention: Right-mild left hand preference trajectory
Number of subjects: 90
Study 31999182 — intervention group
Group type: COMPARATOR
Intervention: Left-moderate right hand preference
Number of subjects: 90
Study 31999182 — intervention group
Group type: COMPARATOR
Intervention: Right-moderate left hand preference
Number of subjects: 90
Study 30332549 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 11
Study 30332549 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 11
Study 27477804 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (CS) 1,200 mg plus glucosamine sulfate (GS) 1,500 mg
Number of subjects: 164
Study 27477804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 27477804 — intervention group
Group type: COMPARATOR
Intervention: Chondroitin sulfate (CS) plus glucosamine sulfate (GS) and Placebo
Number of subjects: 164
Study 26055360 — intervention group
Group type: COMPARATOR
Intervention: RG7667 (1, 3, 5, and 10 mg/kg each antibody; single ascending dose)
Number of subjects: 181
Study 26055360 — intervention group
Group type: COMPARATOR
Intervention: RG7667 (5 and 10 mg/kg each antibody monthly for 3 doses; multiple ascending dose)
Number of subjects: 181
Study 26055360 — intervention group
Group type: COMPARATOR
Intervention: RG7667 (10 mg/kg each antibody monthly for 3 doses; multiple dose expansion)
Number of subjects: 181
Study 26055360 — intervention group
Group type: COMPARATOR
Intervention: RG7667
Number of subjects: 181
Study 23857311 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin (8 mg/d)
Number of subjects: 16
Study 23857311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 21878207 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week progressive home-based program of moderate-intensity aerobic and resistance exercise
Number of subjects: 24
Study 21878207 — intervention group
Group type: COMPARATOR
Intervention: Attention control wait list group performing light stretching and flexibility exercises
Number of subjects: 24
Study 19938905 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 0
Study 19938905 — intervention group
Group type: EXPERIMENTAL
Intervention: Enclomiphene
Number of subjects: 0
Study 19938905 — intervention group
Group type: COMPARATOR
Intervention: Testosterone replacement
Number of subjects: 0
Study 16728222 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (5 to 40 mg)
Number of subjects: 3956
Study 16728222 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 3956
Study 16728222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3956
Study 15327032 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 levels in PP/TPMS
Number of subjects: 73
Study 15327032 — intervention group
Group type: COMPARATOR
Intervention: MMP-9 levels in RRMS
Number of subjects: 73
Study 15327032 — intervention group
Group type: COMPARATOR
Intervention: MMP-9 levels in healthy controls (HC)
Number of subjects: 73
Study 15327032 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MMP-9 levels in PP/TPMS vs RRMS
Number of subjects: 73
Study 15327032 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MMP-9 levels in PP/TPMS vs HC
Number of subjects: 73
Study 11318052 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic mismatch with low memory load methodology
Number of subjects: 0
Study 11318052 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective recall task combined with low memory load methodology
Number of subjects: 0
Study 11318052 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional manipulation
Number of subjects: 0
Study 11318052 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 9863080 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite Divitriol Infusion (CDI)
Number of subjects: 139
Study 9863080 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 139
Study 7945476 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) - transdermal estradiol (50 micrograms daily)
Number of subjects: 200
Study 7945476 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation (400 mg daily)
Number of subjects: 200
Study 7945476 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) in patients taking steroids
Number of subjects: 200
Study 3555580 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg quinine bisulphate at night
Number of subjects: 22
Study 3555580 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum quinine concentration
Number of subjects: 22
Study 3555580 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased nightly dose of quinine
Number of subjects: 22
Study 31232166 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity and educational sessions delivered for six weeks during physical education class.
Number of subjects: 31
Study 31232166 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer measurements taken during the intervention.
Number of subjects: 31
Study 31232166 — intervention group
Group type: EXPERIMENTAL
Intervention: Data collection process for the intervention.
Number of subjects: 31
Study 29505898 — intervention group
Group type: EXPERIMENTAL
Intervention: Eczema Care Plan (ECP)
Number of subjects: 211
Study 29505898 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 211
Study 27071797 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of emotional well-being among adolescents who attended religious services but did not pray privately, feel God's presence, or identify as religious or spiritual.
Number of subjects: 0
Study 27071797 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest overall religious/spiritual group.
Number of subjects: 0
Study 24951828 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent intramuscular norovirus virus-like particle vaccine (50 µg of each VLP)
Number of subjects: 48
Study 24951828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 22058145 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA treatment
Number of subjects: 703
Study 22058145 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 703
Study 22058145 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype analysis
Number of subjects: 703
Study 20572476 — intervention group
Group type: EXPERIMENTAL
Intervention: Navy Sexual Assault Intervention Training (SAIT) program
Number of subjects: 1505
Study 20572476 — intervention group
Group type: COMPARATOR
Intervention: Educational video about HIV/AIDS (comparison condition)
Number of subjects: 1505
Study 18192704 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcitriol 0.75 mcg three times weekly for six weeks
Number of subjects: 5
Study 18192704 — intervention group
Group type: COMPARATOR
Intervention: Oral alfacalcidol 0.75 mcg three times weekly for six weeks
Number of subjects: 5
Study 15983453 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal protocol group (LPG) - bolus of 10 ml/kg followed by 12 ml x kg(‐1) x h(‐1)
Number of subjects: 152
Study 15983453 — intervention group
Group type: COMPARATOR
Intervention: Restrictive protocol group (RPG) - 4 ml x kg(‐1) x h(‐1)
Number of subjects: 152
Study 12028259 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg oral cyanocobalamin
Number of subjects: 31
Study 12028259 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg oral cyanocobalamin
Number of subjects: 31
Study 12028259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 10421886 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulse dye laser (LPDL) with ALA (20% ALA emulsion, 585 nm, 18 J/cm²)
Number of subjects: 200
Study 10421886 — intervention group
Group type: EXPERIMENTAL
Intervention: Incoherent light source with ALA (160 mW/cm², 60-160 J/cm²)
Number of subjects: 200
Study 10421886 — intervention group
Group type: COMPARATOR
Intervention: LPDL without ALA (control group)
Number of subjects: 200
Study 10421886 — intervention group
Group type: EXPERIMENTAL
Intervention: LPDL
Number of subjects: 200
Study 7796066 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational video added to the informed consent procedure for ECT
Number of subjects: 18
Study 7796066 — intervention group
Group type: COMPARATOR
Intervention: Usual written document for informed consent
Number of subjects: 18
Study 2028626 — intervention group
Group type: EXPERIMENTAL
Intervention: Actisomide 4.2 mg/kg
Number of subjects: 0
Study 2028626 — intervention group
Group type: EXPERIMENTAL
Intervention: Actisomide 8.4 mg/kg
Number of subjects: 0
Study 2028626 — intervention group
Group type: EXPERIMENTAL
Intervention: Actisomide 2.1 mg/kg
Number of subjects: 0
Study 365798 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin
Number of subjects: 0
Study 365798 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 27471050 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care programme (IG) including education from a respiratory nurse, physiotherapist support for pulmonary rehabilitation, 3-monthly telephone calls by a respiratory nurse for 1 year, and follow-up at a respiratory clinic with a respiratory specialist once every 3 months for 1 year.
Number of subjects: 180
Study 27471050 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care programme (IG)
Number of subjects: 180
Study 27471050 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (UG)
Number of subjects: 180
Study 26130940 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal extract mouthwash
Number of subjects: 60
Study 26130940 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gluconate mouthwash
Number of subjects: 60
Study 23278871 — intervention group
Group type: EXPERIMENTAL
Intervention: EO mouthrinse
Number of subjects: 90
Study 23278871 — intervention group
Group type: EXPERIMENTAL
Intervention: FM mouthrinse
Number of subjects: 90
Study 23278871 — intervention group
Group type: COMPARATOR
Intervention: Negative control (OHI alone)
Number of subjects: 90
Study 21528592 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with rTMS
Number of subjects: 85
Study 21528592 — intervention group
Group type: COMPARATOR
Intervention: Simple rTMS
Number of subjects: 85
Study 19294472 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatrics home visit program (one home visit to practice geriatric assessment skills, reflective paper, small-group presentation)
Number of subjects: 33
Study 19294472 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatrics home visit program
Number of subjects: 33
Study 17459741 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 243
Study 17459741 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 243
Study 17459741 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention (usual care)
Number of subjects: 243
Study 14752194 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular brachytherapy (n = 8 for PTA, n = 15 for PTA and stent)
Number of subjects: 47
Study 14752194 — intervention group
Group type: COMPARATOR
Intervention: Placebo irradiation (n = 7 for PTA, n = 17 for PTA and stent)
Number of subjects: 47
Study 11572538 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT)
Number of subjects: 21
Study 11572538 — intervention group
Group type: COMPARATOR
Intervention: Sham Therapeutic Touch
Number of subjects: 21
Study 9780750 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH (8 IU during the first five days after the intervention)
Number of subjects: 28
Study 9780750 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional fluid therapy)
Number of subjects: 28
Study 8166152 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg BID
Number of subjects: 105
Study 8166152 — intervention group
Group type: COMPARATOR
Intervention: NPN (neomycin 250 mg QID, polymyxin‐B 100 mg QID, nalidixic acid 1,000 mg BID)
Number of subjects: 105
Study 2980952 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl, 100 micrograms/kg (n = 16)
Number of subjects: 33
Study 2980952 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil, 15 micrograms/kg (n = 17)
Number of subjects: 33
Study 2980952 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 33
Study 29572107 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5% ophthalmic suspension
Number of subjects: 42
Study 29572107 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 42
Study 28028819 — intervention group
Group type: COMPARATOR
Intervention: Fresnel prisms
Number of subjects: 87
Study 28028819 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual search training
Number of subjects: 87
Study 28028819 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 87
Study 26376650 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral perhexiline for a median of 9 days
Number of subjects: 129
Study 23159133 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid solution
Number of subjects: 237
Study 23159133 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid solution
Number of subjects: 237
Study 23159133 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 237
Study 21514555 — intervention group
Group type: EXPERIMENTAL
Intervention: Nugent score 9-10
Number of subjects: 535
Study 21514555 — intervention group
Group type: COMPARATOR
Intervention: Normal flora
Number of subjects: 535
Study 18287394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasted brackets
Number of subjects: 60
Study 18287394 — intervention group
Group type: COMPARATOR
Intervention: Non-sandblasted brackets
Number of subjects: 60
Study 18287394 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall brackets
Number of subjects: 60
Study 18287394 — intervention group
Group type: COMPARATOR
Intervention: Comparison of control and experimental quadrants
Number of subjects: 60
Study 18046927 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled dry powder insulin (IDPI)
Number of subjects: 0
Study 14723792 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dissemination strategy based on The WHO Reproductive Health Library (RHL) including three interactive workshops over six months
Number of subjects: 40
Study 11212627 — intervention group
Group type: EXPERIMENTAL
Intervention: Group decision making
Number of subjects: 0
Study 11212627 — intervention group
Group type: EXPERIMENTAL
Intervention: Group size
Number of subjects: 0
Study 9046141 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium alginate fibre swabs
Number of subjects: 0
Study 9046141 — intervention group
Group type: COMPARATOR
Intervention: Simple gauze swabs
Number of subjects: 0
Study 7914104 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-chlorodeoxyadenosine (2-CdA) administered as a single 120-hour continuous infusion (8.9 mg/m2 of body surface area per day)
Number of subjects: 22
Study 7914104 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-chlorodeoxyadenosine (2-CdA)
Number of subjects: 22
Study 3342158 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 150
Study 3342158 — intervention group
Group type: COMPARATOR
Intervention: Control (no thrombolytic treatment)
Number of subjects: 150
Study 30589098 — intervention group
Group type: EXPERIMENTAL
Intervention: Benidipine (8 mg)
Number of subjects: 0
Study 30589098 — intervention group
Group type: COMPARATOR
Intervention: Rifampin
Number of subjects: 0
Study 27240265 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Therapy (CAT)
Number of subjects: 44
Study 27240265 — intervention group
Group type: COMPARATOR
Intervention: Befriending (supportive treatment)
Number of subjects: 44
Study 25365653 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (300 mg)
Number of subjects: 40
Study 25365653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 24182325 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix (5 mg/day on days 1 and 2; 3 mg/day on days 3-5)
Number of subjects: 99
Study 24182325 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix
Number of subjects: 99
Study 24182325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 22702837 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial participation (n=142)
Number of subjects: 247
Study 22702837 — intervention group
Group type: COMPARATOR
Intervention: Non-participation (n=105)
Number of subjects: 247
Study 19135375 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-vastus approach
Number of subjects: 231
Study 19135375 — intervention group
Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 231
Study 17594733 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized opioids
Number of subjects: 0
Study 17594733 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized furosemide
Number of subjects: 0
Study 16354852 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval exercise (IE) training
Number of subjects: 19
Study 16354852 — intervention group
Group type: COMPARATOR
Intervention: Constant-load exercise (CLE) training
Number of subjects: 19
Study 12230022 — intervention group
Group type: EXPERIMENTAL
Intervention: TW970 (modified formula of chaihu-longu-muli-tang)
Number of subjects: 60
Study 9667097 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 1
Study 9667097 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived barriers against the use of RCTs
Number of subjects: 1
Study 9667097 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence derived from RCTs
Number of subjects: 1
Study 7993833 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative combined chemotherapy (TMF regimen: thiotepa 20 mg, methotrexate 40 mg/m2, 5-fluorouracil 500 mg/m2) plus radiotherapy (Group I)
Number of subjects: 271
Study 7993833 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiation therapy only (Group II)
Number of subjects: 271
Study 7993833 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative combined chemotherapy plus radiotherapy (Group I)
Number of subjects: 271
Study 3140327 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol solution
Number of subjects: 8
Study 3140327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn solution
Number of subjects: 8
Study 3140327 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 8
Study 30376407 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention program promoting personal hygiene
Number of subjects: 143
Study 30376407 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 143
Study 28567696 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress condition of the Maastricht Acute Stress Test (MAST)
Number of subjects: 82
Study 28567696 — intervention group
Group type: COMPARATOR
Intervention: No stress condition of the Maastricht Acute Stress Test (MAST)
Number of subjects: 82